179 related articles for article (PubMed ID: 33480354)
1. Properdin oligomers adopt rigid extended conformations supporting function.
Pedersen DV; Pedersen MN; Mazarakis SM; Wang Y; Lindorff-Larsen K; Arleth L; Andersen GR
Elife; 2021 Jan; 10():. PubMed ID: 33480354
[TBL] [Abstract][Full Text] [Related]
2. Structural Basis for Properdin Oligomerization and Convertase Stimulation in the Human Complement System.
Pedersen DV; Gadeberg TAF; Thomas C; Wang Y; Joram N; Jensen RK; Mazarakis SMM; Revel M; El Sissy C; Petersen SV; Lindorff-Larsen K; Thiel S; Laursen NS; Fremeaux-Bacchi V; Andersen GR
Front Immunol; 2019; 10():2007. PubMed ID: 31507604
[TBL] [Abstract][Full Text] [Related]
3. Insights Into Enhanced Complement Activation by Structures of Properdin and Its Complex With the C-Terminal Domain of C3b.
van den Bos RM; Pearce NM; Granneman J; Brondijk THC; Gros P
Front Immunol; 2019; 10():2097. PubMed ID: 31552043
[TBL] [Abstract][Full Text] [Related]
4. A novel assay that characterizes properdin function shows neutrophil-derived properdin has a distinct oligomeric distribution.
Moore SR; Menon SS; Galwankar NS; Khuder SA; Pangburn MK; Ferreira VP
Front Immunol; 2022; 13():918856. PubMed ID: 36713423
[TBL] [Abstract][Full Text] [Related]
5. Molecular architecture of human properdin, a positive regulator of the alternative pathway of complement.
Smith CA; Pangburn MK; Vogel CW; Müller-Eberhard HJ
J Biol Chem; 1984 Apr; 259(7):4582-8. PubMed ID: 6707020
[TBL] [Abstract][Full Text] [Related]
6. Crystallization and X-ray analysis of monodisperse human properdin.
Pedersen DV; Revel M; Gadeberg TAF; Andersen GR
Acta Crystallogr F Struct Biol Commun; 2019 Feb; 75(Pt 2):0. PubMed ID: 30713161
[TBL] [Abstract][Full Text] [Related]
7. Characterization of mutant forms of recombinant human properdin lacking single thrombospondin type I repeats. Identification of modules important for function.
Higgins JM; Wiedemann H; Timpl R; Reid KB
J Immunol; 1995 Dec; 155(12):5777-85. PubMed ID: 7499866
[TBL] [Abstract][Full Text] [Related]
8. The role of properdin in the assembly of the alternative pathway C3 convertases of complement.
Hourcade DE
J Biol Chem; 2006 Jan; 281(4):2128-32. PubMed ID: 16301317
[TBL] [Abstract][Full Text] [Related]
9. The dimeric and trimeric solution structures of the multidomain complement protein properdin by X-ray scattering, analytical ultracentrifugation and constrained modelling.
Sun Z; Reid KB; Perkins SJ
J Mol Biol; 2004 Nov; 343(5):1327-43. PubMed ID: 15491616
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for the stabilization of the complement alternative pathway C3 convertase by properdin.
Alcorlo M; Tortajada A; Rodríguez de Córdoba S; Llorca O
Proc Natl Acad Sci U S A; 2013 Aug; 110(33):13504-9. PubMed ID: 23901101
[TBL] [Abstract][Full Text] [Related]
11. Functional and structural insight into properdin control of complement alternative pathway amplification.
Pedersen DV; Roumenina L; Jensen RK; Gadeberg TA; Marinozzi C; Picard C; Rybkine T; Thiel S; Sørensen UB; Stover C; Fremeaux-Bacchi V; Andersen GR
EMBO J; 2017 Apr; 36(8):1084-1099. PubMed ID: 28264884
[TBL] [Abstract][Full Text] [Related]
12. Neutron and X-ray scattering studies on the human complement protein properdin provide an analysis of the thrombospondin repeat.
Smith KF; Nolan KF; Reid KB; Perkins SJ
Biochemistry; 1991 Aug; 30(32):8000-8. PubMed ID: 1868073
[TBL] [Abstract][Full Text] [Related]
13. Properdin: emerging roles of a pattern-recognition molecule.
Kemper C; Atkinson JP; Hourcade DE
Annu Rev Immunol; 2010; 28():131-55. PubMed ID: 19947883
[TBL] [Abstract][Full Text] [Related]
14. Expression and characterisation of the thrombospondin type I repeats of human properdin.
Perdikoulis MV; Kishore U; Reid KB
Biochim Biophys Acta; 2001 Aug; 1548(2):265-77. PubMed ID: 11513971
[TBL] [Abstract][Full Text] [Related]
15. Soluble collectin-12 mediates C3-independent docking of properdin that activates the alternative pathway of complement.
Zhang J; Song L; Pedersen DV; Li A; Lambris JD; Andersen GR; Mollnes TE; Ma YJ; Garred P
Elife; 2020 Sep; 9():. PubMed ID: 32909942
[TBL] [Abstract][Full Text] [Related]
16. Local release of properdin in the cellular microenvironment: role in pattern recognition and amplification of the alternative pathway of complement.
Cortes C; Ohtola JA; Saggu G; Ferreira VP
Front Immunol; 2012; 3():412. PubMed ID: 23335922
[TBL] [Abstract][Full Text] [Related]
17. Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assembly.
Spitzer D; Mitchell LM; Atkinson JP; Hourcade DE
J Immunol; 2007 Aug; 179(4):2600-8. PubMed ID: 17675523
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the natural polymeric forms of human properdin and their functions in complement activation.
Pangburn MK
J Immunol; 1989 Jan; 142(1):202-7. PubMed ID: 2909614
[TBL] [Abstract][Full Text] [Related]
19. Properdin Is a Key Player in Lysis of Red Blood Cells and Complement Activation on Endothelial Cells in Hemolytic Anemias Caused by Complement Dysregulation.
Chen JY; Galwankar NS; Emch HN; Menon SS; Cortes C; Thurman JM; Merrill SA; Brodsky RA; Ferreira VP
Front Immunol; 2020; 11():1460. PubMed ID: 32793201
[TBL] [Abstract][Full Text] [Related]
20. Native polymeric forms of properdin selectively bind to targets and promote activation of the alternative pathway of complement.
Ferreira VP; Cortes C; Pangburn MK
Immunobiology; 2010 Nov; 215(11):932-40. PubMed ID: 20382442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
